Learn more

NORCHIP AS

Overview
  • Total Patents
    147
  • GoodIP Patent Rank
    209,128
About

NORCHIP AS has a total of 147 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United Kingdom, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, chemical engineering and machines are BIOFIRE DIAGNOSTICS LLC, IFP PRIV INST PRODUKTQUALITAET and ALERE TECH GMBH.

Patent filings per year

Chart showing NORCHIP ASs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Karlsen Frank 85
#2 Lichtenberg Jan 14
#3 Verpoorte Sabeth 10
#4 Schonfeld Friedhelm 9
#5 Gulliksen Anja 8
#6 Frank Karlsen 7
#7 White Nina Louise 6
#8 Drese Klaus 5
#9 Von Germar Frithjof 5
#10 Sorensen Olaf 5

Latest patents

Publication Filing date Title
GB201310933D0 A method of cervical screening
US2011275698A1 "test and treat" strategy for treating transforming hpv infection
GB0919745D0 Cervical cell collection method
US2011111386A1 Cervical cell collection method
GB0912509D0 A microfabricated device for metering an analyte
GB0820720D0 Method for worldwide screening of pre-cancer epithelial disease of the cervix
GB0810450D0 Microfabricated device
GB0710957D0 A device for carrying out cell lysis and nucleic acid extraction
GB0427011D0 Portable incubator device
GB0426082D0 A device for carrying out biological assays
GB0404315D0 Improved detection of human papillomavirus
GB0401868D0 A diagnostic system for carrying out a nucleic acid sequence amplification and detection process
GB0328402D0 Portable incubator device
US2006057581A1 Microfabricated fluidic device for fragmentation
NZ533703A Method for detecting human papillomavirus mRNA
US7867757B2 Fluid manipulation in a microfabricated reaction chamber systems
GB0228422D0 Portable incubator device
GB0225539D0 Fluid manipulation in a microfabricated reaction chamber system
GB0225537D0 A microfabricated fluidic device for nucleic acid extraction
GB0216405D0 Detection of human papillomavirus mRNA